Long‐term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)‐inactivated vaccine in PRRSV‐endemically infected sows
- 26 July 2006
- journal article
- Published by Wiley in Journal of Veterinary Medicine, Series B
- Vol. 53 (6) , 266-272
Abstract
Summary: The purpose of this study was to investigate the safety and efficacy of a commercial European porcine reproductive and respiratory syndrome virus (PRRSV)‐inactivated vaccine after 18‐month use in gilts/sows at a farm with high seroprevalence. In a farrow‐to‐finish farm with 1100 sows, all sows and gilts were systematically vaccinated with the PRRS‐inactivated PROGRESSIS® vaccine for a period of 18 months. Farm's reproductive and litter characteristics were longitudinally recorded for this period and historically compared with those of the year prior to vaccination. Serology, employing immunoperoxidase monolayer assay, had confirmed a high prevalence of PRRS‐specific antibodies in most age groups within the farm prior to vaccination. Seroprevalence during the experiment ranged between 0% and 100% in weaners and growers, but remained at stable high levels (>93%) in finishing pigs and gilts throughout all 2‐year period of serology measurements. No local or systemic vaccine side effects were noted throughout the trial period. Vaccinations had resulted over time in a significant improvement of sow reproductive performance (e.g. reduction of premature farrowings, abortions and increase of farrowing rate) and litter characteristics (e.g. increase of the number of live born and weaned pigs and decrease of stillborn, mummified, weak and splay‐legged piglets). It has also been observed that the higher the degree of immunization of a sow, the better the improvement of her reproductive parameters. Sows after vaccination have shown improved characteristics compared to homoparous sows prior to the application of vaccinations in the farm.Keywords
This publication has 26 references indexed in Scilit:
- Porcine Reproductive and Respiratory Syndrome (PRRS) Virus-Specific Interferon-γ + T-Cell Responses After PRRS Virus Infection or Vaccination with an Inactivated PRRS VaccineViral Immunology, 2005
- Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacyVaccine, 2004
- Molecular epidemiology of porcine reproductive and respiratory syndrome virus (PRRSV) in QuébecVirus Research, 2003
- Results of a control programme for the porcine reproductive and respiratory syndrome in the French ‘Pays de la Loire’ regionVeterinary Microbiology, 1997
- Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virusArchives of Virology, 1995
- Characterization of the Humoral Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Virus InfectionJournal of Veterinary Diagnostic Investigation, 1995
- Prevention of the spread of porcine reproductive and respiratory syndrome virus in endemically infected pig herds by nursery depopulationVeterinary Record, 1994
- Endemic Porcine Reproductive and Respiratory Syndrome Virus Infection of Nursery Pigs in Two Swine Herds without Current Reproductive FailureJournal of Veterinary Diagnostic Investigation, 1993
- Antigenic Comparison of Lelystad Virus and Swine Infertility and Respiratory Syndrome (SIRS) VirusJournal of Veterinary Diagnostic Investigation, 1992
- Isolation of Swine Infertility and Respiratory Syndrome Virus (Isolate ATCC VR-2332) in North America and Experimental Reproduction of the Disease in Gnotobiotic PigsJournal of Veterinary Diagnostic Investigation, 1992